Protagonist Therapeutics, Inc. (PTGX) Social Stream



Protagonist Therapeutics, Inc. (PTGX): $17.19

0.08 (+0.47%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

PROTAGONIST THERAPEUTICS INC (PTGX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering PTGX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-14 7 $93 $40 $56.857 $17.68 221.59%
2021-11-15 7 $93 $40 $58.285 $17.68 229.67%
2022-01-27 7 $93 $40 $59 $17.68 233.71%
2022-03-02 8 $93 $40 $58.5 $17.68 230.88%
2022-04-25 8 $93 $40 $58 $17.68 228.05%
2022-04-26 8 $93 $40 $56.75 $17.68 220.98%
2022-05-05 8 $93 $30 $51.75 $17.68 192.7%
2022-05-06 8 $70 $30 $47.625 $17.68 169.37%
2022-05-09 8 $70 $30 $46.875 $17.68 165.13%
2022-05-17 8 $70 $30 $43.75 $17.68 147.45%
2022-07-21 6 $70 $30 $44.166 $17.68 149.81%
2022-08-05 6 $70 $30 $44.285 $17.68 150.48%
2022-08-25 7 $50 $21 $37.285 $17.68 110.89%
2022-09-28 7 $50 $21 $36 $17.68 103.62%
2022-11-09 6 $50 $21 $37 $17.68 109.28%
2023-01-17 6 $45 $21 $34.166 $17.68 93.25%
2023-03-08 4 $45 $31 $35.833 $17.68 102.68%
2023-03-16 5 $45 $31 $36.666 $17.68 107.39%
2023-03-20 5 $45 $29 $35.666 $17.68 101.73%
2023-05-08 5 $38 $29 $33.8 $17.68 91.18%
2023-05-12 5 $38 $30 $34 $17.68 92.31%
2023-05-25 5 $40 $31 $36 $17.68 103.62%
2023-07-03 5 $49 $31 $37.8 $17.68 113.8%
2023-08-04 6 $49 $35 $39 $17.68 120.59%

The Trend in the Analyst Price Target


PTGX's average price target has moved down $7.88 over the prior 15 months.

PTGX reports an average of 146.1% for its upside potential over the past 44 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-09-28 7 50 21 36.000 8.81 308.63%
2023-01-17 6 45 21 34.166 11.65 193.27%
2023-03-16 5 45 31 36.666 23.15 58.38%
2023-06-25 5 49 31 37.800 27.61 36.91%
2023-07-03 5 49 31 37.800 22.31 69.43%

PTGX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 6 0 0 0 0 6

The Trend in the Broker Recommendations


PTGX's average broker recommendation rating improved by 0 over the prior 153 days.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • PROTAGONIST THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 2576.3% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, PROTAGONIST THERAPEUTICS INC's variance in analysts' estimates is lower than -2159.84% of them.
  • PROTAGONIST THERAPEUTICS INC's number of analysts covering the stock is greater than 1195.91% of stocks in the mid market cap category.
  • PROTAGONIST THERAPEUTICS INC's average analyst price target is higher than 2063.27% of Pharmaceutical Products stocks.

Stocks similar to PROTAGONIST THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RETA, AXSM, and BPMC.

What is the outlook for PTGX? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!